Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Cannabis reclassification could 'open the floodgates' for research, scientists say- Investigating Remarkable Espresso Flavors: Upgrade Your Day to day Blend
- Vote in favor of Your Number one BWM Vehicles
- Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'
- 6 Modest and Strong Tire Brands
- Saturn's moon Titan may not have a buried ocean as long suspected, new study suggests
- China bans storing cremated remains in empty 'bone ash apartments'
- Will Comet C/2025 R3 (PanSTARRS) be the 'great comet' of 2026?
- Watch interstellar comet 3I/ATLAS make its closest approach to Earth in free livestream on Dec. 18
